Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Industry News

| More

New Zealand aids drug delivery research at IIT Bombay

Posted On: 2012-10-16 20:30:57

Drug delivery research in India will advance with help from New Zealand, with the gift of a highly advanced qNano system to Prof. Rinti Banerjee from the Department of Biosciences & Bioengineering at the Indian Institute of Technology (IIT) in Mumbai.

New Zealand nanotechnology company Izon Science gifted the instrument to accelerate advancement of research in the area of nanoparticles for drug delivery. The gift recognises the path-breaking technology platform and drug delivery mechanism award winning Prof. Rinti Banerjee has developed. The qNano provides the highly accurate information required to aid development of drug delivery systems that could deliver cancer drugs directly to the tumor.

The qNano system was presented to Prof. Banerjee by Hans van der Voorn, the Executive Chairman of Izon Science. The function held at IIT Bombay was attended by Hon Steven Joyce, New Zealand's Science and Innovation Minister, as part of his visit to India with a delegation of New Zealand education and aviation companies. Acting Director of IIT Bombay, Prof. R.K. Malik and Prof. N.S. Punekar, Head of Department of Biosciences & Bioengineering were also present at the occasion.

Prof. Banerjee is the winner of numerous awards for her work including most recently the prestigious National Award for Women Bio-scientists by the Department of Biotechnology, Government of India.

Her group works in the area of nanomedicine. Her group focuses on development of non-invasive carriers for delivery of drugs using specifically engineered nanoparticle technologies.

At present the technologies are being developed for therapy in cancers, respiratory diseases, ocular diseases and malnutrition. Several technologies developed by her group have been patented and have shown promising effects in in vivo animal models. Prof. Banerjee is keen to collaborate with industrial partners for further translation of these technologies.

Gavin Young, New Zealand's Trade Commissioner and Consul General in Mumbai says, "It's great to see a New Zealand company helping researchers in India at the forefront of new research frontiers. New Zealand's focus on science and innovation is something we share with India."

Izon Science's Hans van der Voorn says, "We're very pleased to be contributing to Prof. Banerjee's very important research work into controlled release drug delivery. This research could lead to the development of high value added products that could really make a difference to people's wellbeing worldwide, as well as to the Indian economy.

"This gift is a sign of our commitment to building business and research relationships in India. Half of our global sales already come from Asia and we see India as a very important market going forward."

Prof. Banerjee says, "I am thankful to Izon Science, New Zealand for presenting me with qNano which is a state-of-the art piece of equipment renowned for its precise measurements of nanoparticle sizes and concentrations. I am very excited that qNano will help us in accelerating our translational efforts in nanoparticle based drug delivery for affordable therapies in cancers and other diseases worldwide."

Targeted drug delivery offers enormous health benefits as smaller doses of drugs are delivered directly and achieve delivery of therapeutic levels of drugs over long periods of time without dose fluctuations. Targeted drug delivery also result in fewer side effects than pulse entry drug delivery. Targeted delivery of cancer drugs directly to the tumor is seen as a key application.

Prof. Banerjee is also interested in using drug loaded biological nanoparticles for respiratory, ophthalmic and transdermal delivery of drugs. The main objective is to design nanoparticles to reduce the systemic toxicity of the drugs and administer them through non-invasive, patient compliant routes.

"The qNano is a great way to enable researchers and students alike to do high quality bio and nanotechnology research and to be on the forefront of new research frontiers. Our instruments are extremely accurate and very affordable. One electron microscope is about the same price as 25 or 30 qNanos and our instruments are actually more accurate for particle research," says van der Voorn.

Izon Science's qNano and qViro instruments enable extremely precise measurement of nano and micro-particle samples by measuring the physical properties (size, concentration and surface charge) of individual particles as they pass through the unique size-tunable nanopores. The instruments are advancing research in a number of fields including drug delivery, hematology, biomedical diagnostics, and vaccine development.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

2.0 Audio Launch Sets Benchmark for International Film Events in Dubai
BSE and Ebix Sign MOU to Launch Joint Venture Company
Comments on on 'Pradhan Mantri Sahaj Bijli Har Ghar Yojana' - Power for All
SVC Bank launches hassle-free ASBA facility for IPOs
Flipkart's Big Billion Days To Kick In From September 20
Genpact Acquires Digital Customer Experience Consulting Firm TandemSeven
PAYBACK India Announces Appointment of new CEO
IndiaFirst Life acknowledged with Social Inclusion Award 2017 by Fintelekt
Apollo Munich Launches India's First Travel Insurance Chatbot - 'Travel Ninja'
On its run up to an IPO, ShopClues appoints Deepak Sharma as CFO
Cognizant Opens New Digital Business Collaboratory in London
Morphy Richards appoints J Walter Thompson as their creative agency
edX partners with IL&FS / IFIN to launch learning academy
PAYBACK India wins the Best Loyalty Program 2017 award at CMO Asia 'National Awards for Marketing Excellence'
Hyundai Launches the Most Unique & Global 'Online Buying Experience'- 'HyBuy'
Myntra launches The Game of Thrones collection ahead of the much awaited season 7
DBS Bank Strengthens India franchise on 24% growth in advances and 15% in deposits during FY 2016-17
Apollo Munich Health Insurance ranked as top 'Great place to Work' in Indian Insurance Sector
92.7 BIG FM's New and Refreshed Stationality in Bengaluru, Celebrates Music With 'Sandalwood Jothe Bollywood Blast'
Omega Healthcare inaugurates 4th facility in Trichy
Broadridge Opens Fourth Office in India in Bangalore
Myntra targets 25x sales; 4 lakh new customers during the 6th edition of its flagship - 'End of Reason Sale'!
ARQ Midcap stocks gives its investors' 42.66% return on investments
Now check Train PNR status after booking tickets on Paytm
LANXESS to streamline the chrome value chain of its leather business
BankBazaar android app crosses 1Million downloads
Amazon.in launches 'GST Cafés' to train sellers on GST compliance
Overnite Express looking for franchise to expand all across the country
Salman Khan's Tubelight to be released across 4400 screens in India
Paytm introduces zero cancellation-handling fees for flight tickets
Finvasia introduces Zero brokerage trading - The new age of stock trading arrives
AGS Transact Technologies Limited to implement Automatic Fare Collection system for the Kochi Metro
LANXESS expects best results in company history in 2017
NIIT University (NU) addresses IT industry's urgent need for Next Gen digitally skilled engineers
Union Ministry of Food Processing Industries launches World Food India Website www.worldfoodindia.in
Hospitals, bidi workers and public health organizations welcome's GST Council decision to tax all tobacco products including bidis at 28% saving millions of lives
Gionee India Ropes In Prabhas as Brand Ambassador; Welcomes A Mighty Addition to The World Of #Selfiestan
Angel Broking bags prestigious 'Commodity Broker of the Year Award'
Angel Broking brings UPI in Investing
Bayer wins 'Best Employer in India 2017' Award
Yogi Adityanath cancels bids to procure 3800 MW power: Angel Broking
India's Buying Propensity Soars in January 2017, Dips Sharply in March
Start ups - Blue Ocean Market Intelligence and HelloSoda India win Angel Broking's Fintech Challenge
IBM and Red Hat Collaborate to Accelerate Hybrid Cloud Adoption with OpenStack
Elara Technologies Introduces a Un ique Offering for the Indian Real Estate Ecosystem for International Exposure
Tally Solutions joins hands with The Guild and CNBC Awaaz as Technology Partner and conducts its 'SME Futures' program in Hyderabad
Birlasoft Announces TruView CLM - a Salesforce Fullforce Solution for Media & Entertainment industry
Manipal CDC's new platform makes maiden investment in iGenetic Diagnostics
Tractors India Private Limited inks deal with RungePincockMinarco to deliver enterprise solutions for the Digital Mines of the Future
NASSCOM President Concludes Visit to Washington, DC


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017